Assay for SARS coronavirus by amplification and detection of nucleocapsid RNA sequence

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the nucleocapsid gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARSCoV infection.

Saved in:
Bibliographic Details
Main Authors YURSIS DARETTA ANN, HELLYER TOBIN JAMES, PRICE JAMES ARTHUR JR, LOU JIANRONG, KELLER LISA MARIE, WOLFE DAVID MICHAEL
Format Patent
LanguageChinese
English
Published 07.11.2012
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
DIAGNOSIS
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
SURGERY
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the nucleocapsid gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARSCoV infection.
Bibliography:Application Number: CN2004829100